Xenon Pharmaceuticals Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Xenon Pharmaceuticals Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q2 2024.
  • Xenon Pharmaceuticals Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 75.7M shares, a 18.8% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 75.7M +11.9M +18.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 75.5M +12.4M +19.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 75.4M +12.8M +20.4% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 65M +2.46M +3.93% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 63.7M +1.48M +2.37% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 63.1M +10M +18.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 62.6M +11M +21.2% Dec 31, 2022 10-K 2024-02-29
Q3 2022 62.5M +21.1M +51% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 62.2M +21.1M +51.4% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 53.1M +12.1M +29.5% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 51.6M +16.6M +47.5% Dec 31, 2021 10-K 2023-03-01
Q3 2021 41.4M +6.42M +18.3% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 41.1M +6.12M +17.5% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 41M +6.01M +17.2% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 35M +6.87M +24.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 35M +9.13M +35.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 35M +9.22M +35.8% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 35M +9.18M +35.6% Mar 31, 2020 10-Q/A 2020-05-26
Q4 2019 28.1M +2.39M +9.28% Dec 31, 2019 10-K 2021-03-01
Q3 2019 25.9M +681K +2.7% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 25.8M +8.13M +46.1% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 25.8M +11.6M +81.9% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 25.8M +7.75M +43.1% Dec 31, 2018 10-K 2020-03-09
Q3 2018 25.2M +7.19M +39.9% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 17.6M -357K -1.99% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 14.2M -3.83M -21.3% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 18M +67.8K +0.38% Dec 31, 2017 10-K 2019-03-06
Q3 2017 18M +105K +0.59% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 18M +3.58M +24.9% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 18M +3.6M +25% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 17.9M +3.55M +24.6% Dec 31, 2016 10-K 2018-03-07
Q3 2016 17.9M +3.55M +24.7% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 14.4M +148K +1.04% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 14.4M +179K +1.26% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 14.4M +204K +1.44% Dec 31, 2015 10-K 2017-03-08
Q3 2015 14.3M +13M +963% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 14.3M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 14.2M Mar 31, 2015 10-Q/A 2015-08-13
Q4 2014 14.2M +12.8M +955% Dec 31, 2014 10-K 2016-03-08
Q3 2014 1.35M Sep 30, 2014 10-Q 2014-12-15
Q4 2013 1.34M Dec 31, 2013 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.